Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk

European Heart Journal

Volumn 19, Issue 3, 1998, Pages 387-394

  Birnie, D H ^a,b   Holme, E R ^a   McKay, I C ^a   Hood, S ^a   McColl, K E L ^a   Hillis, W S ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Anti mhsp65; Auto immunity; Coronary atherosclerosis; Heat shock protein 65; Helicobacter pylori

Indexed keywords

ANTIBIOTIC AGENT; ANTIBODY; CHOLESTEROL; FIBRINOGEN; HEAT SHOCK PROTEIN 65; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FIBRINOGEN BLOOD LEVEL; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BIOLOGICAL MARKERS; CHAPERONINS; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; LINEAR MODELS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0032032277     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1997.0618     Document Type: Article

References (26)

1. [1] Mendall M, Goggin P, Levy J et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71: 437-9.
2. [2] Patel P, Carrington D, Strachan D et al. Fibrinogen: a link between chronic infection and coronary heart disease. Lancet 1994; 343: 1634.
3. [3] Patel P, Mendall MA, Carrington D et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br Med J 1995; 311: 711-14.
4. [4] Murray LJ, Bamford KB, O'Reilly PJD, McCrum EE, Evans AE. Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease and social class. Br Heart J 1995; 74: 497-501.
5. [5] Hansson GK. Immune and inflammatory mechanisms in the development of atherosclerosis. Br Heart J 1993; 69 (Suppl): S38-S41.
6. [6] Wick G, Schett G, Anberger A, Kleindienst R, Xu Q. Is atherosclerosis an immunologically mediated disease? Immunol Today 1995; 16: 27-33.
7. [7] Hansson GK. Immunological markers of atherosclerosis. Lancet 1993; 341: 278.
8. [8] Xu Q, Dietrich H, Steiner HJ et al. Induction of arteriosclerosis in normocholesterolaemic rabbits by immunisation with heat shock protein 65. Arterioscler Thromb 1992; 12: 789-99.
9. [9] Xu Q, Kleindienst R, Waitz W, Dietrich H, Wick G. Increased expression of Heat Shock Protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to Heat Shock Protein 65. J Clin Invest 1993; 91: 693-702.
10. [10] Kleindienst R, Xu Q, Willeit J, Waldenberger JR, Weimann S, Wick G. Demonstration of Heat Shock Protein 60 expression and T lymphocytes bearing α/β or γ/δ receptor in human atherosclerotic lesions. Am J Pathol 1993; 142: 1927-37.
11. [11] Xu Q, Willeit J, Marosi M, Kleindienst R, Oberhollenzer F, Kiechl S et al. Association of serum antibodies to Heat Shock Protein 65 with carotid atherosclerosis. Lancet 1993; 341: 225-9.
12. [12] Hoppichler F, Lechleitner M, Traweger C et al. Changes of serum antibodies to heat shock protein 65 in coronary heart disease and acute myocardial infarction. Atherosclerosis 1996; 126: 333-8.
13. [13] Heng MK, Heng CY. Heat shock protein 65 and activated γ/δ T cells in injured arteries. Lancet 1994; 344: 921-3.
14. [14] Birnie D, McKay IC, Veitch J et al. Antimycobacterial hsp65 and rheumatoid factor titres in a population of normal twins: evidence of genetic control of rheumatoid factor. Clin Exp Immunol 1995; 101: 393-6.
15. [15] Thompson SJ, Hitsumoto Y, Shoiaishia M, Webb R, Elson CJ. Environmental influences on the development of pristane-induced arthritis. Arthritis Rheum 1992; 35: 139.
16. [16] Evans DJ, Evans DG, Engstrand LM, Graham DY. Urease-associated heat shock protein of Helicobacter pylori. Infect Immun 1992; 60: 2125-7.
17. [17] Sharma SA, Miller GG, Perez-Perez GI, Gupta RS, Blaser MJ. Humoral and cellular immune recognition of Helicobacter pylori proteins are not concordant. Clin Exp Immunol 1994; 97: 126-32.
18. [18] Burdon RH. Heat shock proteins in relation to medicine. Molec Aspects Med 1993; 14: 85-165.
19. [19] McLoone P. Carstairs scores for Scottish Postcode sectors from the 1991 Census. Public Health Research Unit, University of Glasgow.
20. [20] Feldman RA, Deeks JJ, Evans SJW and the Helicobacter Pylori Serology Study Group. Multi-laboratory comparison of eight commercially available Helicobacter pylori serology kits. Eur J Clin Microbiol Infect Dis 1995; 14: 428-33.
21. [21] Negri M, Sheiban I, Arigliano P et al. Interrelation between angiographic severity of coronary artery disease and plasma levels of insulin, C-peptide and plasminogen activator Inhibitor-1. Am J Cardiol 1993; 72: 397-401.
22. [22] Oberman A, Jones WB, Riley CP, Reeves TJ, Sheffield LT, Turner ME. Natural history of coronary artery disease. Bull NY Acad Med 1972; 48: 1109-125.
23. [23] Sullivan DR, Marwick TH, Freedman SB. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J 1990; 119: 1262.
24. [24] Grayston JT. Chlamydia in Atherosclerosis. Circulation 1993; 87: 1408-9.
25. [25] Ward ME. The immunobiology and immunopathology of chlamydial infections. APMIS 1995; 103: 769-96.
26. [26] Alexander RW. Inflammation and coronary artery disease. N Engl J Med 1994; 331: 468-649.